MarketCap
Facebook
X
TelegramQuarterly report 2022-Q3
added 11-10-2022
Viveve Medical DSO Ratio 2011-2026 | VIVE
Annual DSO Ratio Viveve Medical
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 37.5 | 51.3 | 87.4 | 112 | 148 | 107 | 150 | 24.3 | 144 | 136 | 246 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 246 | 24.3 | 113 |
Quarterly DSO Ratio Viveve Medical
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | 45 | 33.3 | 29.4 | - | 34.2 | 28.5 | 34.8 | - | 46.1 | 99.8 | 82 | - | 136 | 136 | 110 | - | 108 | 94.2 | 147 | - | 139 | 184 | 125 | - | 103 | 123 | 95.4 | - | 92.7 | 741 | 719 | - | 32.2 | 7.5 | 493 | - | 6.91 K | 87.3 | 119 | - | 173 | 101 | 1.95 K | - | 1.53 K | 104 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 6.91 K | 7.5 | 428 |
DSO Ratio of other stocks in the Medical devices industry
| Issuer | DSO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
BioSig Technologies
BSGM
|
607 | - | 37.08 % | $ 85.7 M |  USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
44.2 | - | - | $ 1.77 B | USA |
 |
Beyond Air
XAIR
|
50.7 | $ 0.72 | 3.86 % | $ 48.7 M | USA |
 |
Axonics Modulation Technologies
AXNX
|
49.2 | - | - | $ 3.31 B | USA |
 |
Lianluo Smart Limited
LLIT
|
215 | - | 24.59 % | $ 44.8 M |  China |
 |
Dynatronics Corporation
DYNT
|
41.6 | - | 14.99 % | $ 929 K | USA |
 |
Aziyo Biologics
AZYO
|
59.5 | - | 1.37 % | $ 20.5 M | USA |
 |
Acutus Medical
AFIB
|
746 | - | -26.83 % | $ 2.62 M | USA |
 |
Xtant Medical Holdings
XTNT
|
64.4 | $ 0.54 | -4.43 % | $ 72.2 M | USA |
 |
Zimmer Biomet Holdings
ZBH
|
69.5 | $ 88.29 | -0.97 % | $ 17.9 B | USA |
 |
Allied Healthcare Products
AHPI
|
161 | - | 3.58 % | $ 2.21 M | USA |
 |
Align Technology
ALGN
|
86.7 | $ 165.93 | -6.43 % | $ 12.4 B | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
724 | - | -5.86 % | $ 30.6 M | USA |
 |
Alphatec Holdings
ATEC
|
43.1 | $ 10.9 | -5.43 % | $ 1.64 B | USA |
 |
Conformis
CFMS
|
55.4 | - | - | $ 16.4 M | USA |
 |
Accuray Incorporated
ARAY
|
69.7 | $ 0.39 | 4.51 % | $ 40.1 M | USA |
 |
Abbott Laboratories
ABT
|
61.2 | $ 104.33 | -0.23 % | $ 182 B | USA |
 |
Cardiovascular Systems
CSII
|
61.6 | - | 0.15 % | $ 844 M | USA |
 |
Second Sight Medical Products
EYES
|
49.1 | - | -0.97 % | $ 54.4 M | USA |
 |
Apollo Endosurgery
APEN
|
59.5 | - | - | $ 475 M | USA |
 |
Boston Scientific Corporation
BSX
|
65.7 | $ 69.42 | -1.07 % | $ 103 B | USA |
 |
Avinger
AVGR
|
49.4 | - | -20.74 % | $ 369 K | USA |
 |
CryoLife, Inc.
CRY
|
70.3 | - | -4.14 % | $ 702 M | USA |
 |
CHF Solutions, Inc.
CHFS
|
52.9 | - | 1.15 % | $ 34.5 M | USA |
 |
CONMED Corporation
CNMD
|
64.5 | $ 34.68 | -5.35 % | $ 1.08 B | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
62.7 | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
85.4 | - | 0.03 % | $ 1.58 B |  Israel |
 |
NanoVibronix
NAOV
|
29.7 | - | - | $ 1.08 M | USA |
 |
Misonix, Inc.
MSON
|
64.6 | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
120 | - | - | $ 111 M |  Canada |
 |
Intersect ENT, Inc.
XENT
|
66.1 | - | - | $ 955 M | USA |
 |
Cytosorbents Corporation
CTSO
|
68.6 | $ 0.6 | -0.18 % | $ 32.7 M | USA |
 |
Aethlon Medical
AEMD
|
40.7 | $ 2.14 | -5.73 % | $ 3.34 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
38.2 | $ 79.45 | -3.23 % | $ 46.5 B | USA |
 |
BIOLASE
BIOL
|
42 | - | -13.19 % | $ 166 K | USA |
 |
AdaptHealth Corp.
AHCO
|
43.8 | $ 11.11 | -2.63 % | $ 1.5 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
74.3 | $ 15.65 | -4.31 % | $ 367 M | USA |
 |
Invacare Corporation
IVC
|
206 | - | - | $ 24.7 M | USA |
 |
Ra Medical Systems
RMED
|
2.15 K | - | 10.0 % | $ 610 K | USA |
 |
Myomo
MYO
|
35.3 | $ 0.67 | -1.26 % | $ 28 M | USA |
 |
Penumbra
PEN
|
46.5 | $ 335.28 | -0.34 % | $ 13 B | USA |
 |
Inspire Medical Systems
INSP
|
42.6 | $ 49.77 | -1.35 % | $ 1.46 B | USA |
 |
Pulmonx Corporation
LUNG
|
50.8 | $ 1.17 | -5.65 % | $ 47.6 M | USA |
 |
Cutera
CUTR
|
327 | - | -10.19 % | $ 1.99 M | USA |
 |
Eargo
EAR
|
70.8 | - | - | $ 10.2 M | USA |
 |
NuVasive
NUVA
|
70.4 | - | - | $ 2.07 B | USA |
 |
Nevro Corp.
NVRO
|
67.6 | - | - | $ 217 M | USA |
 |
Surgalign Holdings
SRGA
|
78.5 | - | -32.98 % | $ 1.68 M | USA |
 |
STRATA Skin Sciences
SSKN
|
39.9 | - | - | $ 6.6 M | USA |